1: Tamari K, Sano K, Li Z, Seo Y, Otani K, Tatekawa S, Toratani M, Takaoka Y, Takahashi Y, Minami K, Isohashi F, Koizumi M, Ogawa K. Ro 90-7501 Is a Novel Radiosensitizer for Cervical Cancer Cells that Inhibits ATM Phosphorylation. Anticancer Res. 2019 Sep;39(9):4805-4810. doi: 10.21873/anticanres.13665. PMID: 31519582.
2: Hong TJ, Park K, Choi EW, Hahn JS. Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism. Biochem Biophys Res Commun. 2017 Jan 8;482(2):215-220. doi: 10.1016/j.bbrc.2016.11.043. Epub 2016 Nov 10. PMID: 27840051.
3: Guo F, Mead J, Aliya N, Wang L, Cuconati A, Wei L, Li K, Block TM, Guo JT, Chang J. RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response. PLoS One. 2012;7(10):e42583. doi: 10.1371/journal.pone.0042583. Epub 2012 Oct 3. PMID: 23056170; PMCID: PMC3463586.
4: Falci Finardi N, Kim H, Hernandez LZ, Russell MRG, Ho CM, Sreenu VB, Wenham HA, Merritt A, Strang BL. Identification and characterization of bisbenzimide compounds that inhibit human cytomegalovirus replication. J Gen Virol. 2021 Dec;102(12):001702. doi: 10.1099/jgv.0.001702. PMID: 34882533; PMCID: PMC8744270.
5: Rebbeck R, Ginsburg KS, Ko CY, Fasoli A, Rusch K, Cai GF, Dong X, Thomas DD, Bers DM, Cornea RL. Synergistic FRET assays for drug discovery targeting RyR2 channels. J Mol Cell Cardiol. 2022 Jul;168:13-23. doi: 10.1016/j.yjmcc.2022.04.002. Epub 2022 Apr 9. PMID: 35405106; PMCID: PMC10088286.
6: Li X, Li X, Wang H, Zhao X. Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by comprehensive bioinformatics analysis and molecular docking. BMC Musculoskelet Disord. 2023 Jun 29;24(1):532. doi: 10.1186/s12891-023-06664-8. PMID: 37386410; PMCID: PMC10308648.
7: Zhou F, Liu Y, Liu D, Xie Y, Zhou X. Identification of basement membrane- related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma. J Cancer. 2024 Jan 1;15(2):401-417. doi: 10.7150/jca.89665. PMID: 38169540; PMCID: PMC10758037.
8: Alakwaa FM. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data. mSystems. 2020 Apr 14;5(2):e00297-20. doi: 10.1128/mSystems.00297-20. PMID: 32291351; PMCID: PMC7159901.
9: Zulauf KE, Kirby JE. Discovery of small-molecule inhibitors of multidrug- resistance plasmid maintenance using a high-throughput screening approach. Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29839-29850. doi: 10.1073/pnas.2005948117. Epub 2020 Nov 9. PMID: 33168749; PMCID: PMC7703651.
10: Ma D, Yang Y, Cai Q, Ye F, Deng X, Shen B. Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs. Front Genet. 2022 Sep 14;13:973444. doi: 10.3389/fgene.2022.973444. PMID: 36186449; PMCID: PMC9515791.
11: Sun Q, Li YJ, Ning SB. Investigating the molecular mechanisms underlying the co-occurrence of Parkinson's disease and inflammatory bowel disease through the integration of multiple datasets. Sci Rep. 2024 Jul 24;14(1):17028. doi: 10.1038/s41598-024-67890-1. PMID: 39043798; PMCID: PMC11266657.
12: Bohrmann B, Adrian M, Dubochet J, Kuner P, Müller F, Huber W, Nordstedt C, Döbeli H. Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates. J Struct Biol. 2000 Jun;130(2-3):232-46. doi: 10.1006/jsbi.2000.4241. PMID: 10940228.